par
Lynn Shapiro, Writer | August 13, 2008
The technique could also be applied after chemotherapy, the authors suggest, in cases where the drugs had eliminated most of the smaller cancers, leaving only a few larger tumors behind.
The trial is still underway. "We now have about 50 patients," said Weichselbaum, "and several of them remain disease-free, one of them three years after treatment."
Ad Statistics
Times Displayed: 44187
Times Visited: 1363 Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.
Back to HCB News
